ESTIMATION OF PORTAL BLOOD FLOW USING DUPLEX REAL-TIME AND PULSED DOPPLER ULTRASOUND IMAGING IN THE DOG

A duplex ultrasound system incorporating a pulsed wave Doppler ultrasound probe with conventional B-mode real-time imaging was used to evaluate portal vein blood flow in eight normal dogs. Adequate visualization of the cranial abdominal vessels was obtained from the right lateral 11th or 12th intercostal space. Doppler spectral analysis showed non-pulsatile flow with a wide range of linear flow velocities across the vessel lumen typical of laminar blood flow. Results for portal vein blood flows were 49.8 ± 13.5 ml/min/kg body weight (mean ± SD) with a range of 37.8 - 76.8 ml/min/kg body weight. These values overestimate portal blood flow by approximately 2 times when compared with published studies using invasive techniques. This overestimation is primarily due to the use of the maximal flow velocity in the blood flow calculations.     

Evaluation of Two Reagent Strips and Three Reflectance Meters For Rapid Determination of Blood Glucose Concentrations

We evaluated three reflectance meters (Accu-Chek II, Glucometer II, and Glucoscan 2000) and two reagent strips (Chemstrip bG and Glucostix) for accuracy and precision in determining blood glucose concentrations in the dog. To evaluate accuracy, we compared results of blood glucose determinations performed on 95 samples using the various strips and meters vs. the glucose concentrations obtained using the glucose-oxidase method on a Beckman Glucose Analyzer. Accuracy was evaluated statistically using least squares regression analysis. To evaluate precision, samples in various ranges of blood glucose concentration were tested repeatedly (20 times within a 1-hour period) on the same reflectance meter. Coefficient of variation (CV) was determined to evaluate reproducibility of results. Overall, there were significant correlations (P less than 0.001) between the laboratory glucose values and the blood glucose concentrations obtained with Chemstrip bG (r = 0.976), Glucostix (r = 0.904), Accu-Chek II (r = 0.986), Glucometer II (r = 0.911) and Glucoscan 2000 (r = 0.944). In the precision study, all three meters had excellent CVs in the normal range (3.6% to 4.9%). However, Accu-Chek II was found to be more precise in the hypoglycemic and hyperglycemic ranges (3.6% and 2.6%, respectively) than either Glucometer II (8.8% and 5.4%) or Glucoscan 2000 (7.8% and 8.2%). The results of this study indicate that all of the meters and reagent strips tested are highly accurate in determining blood glucose concentrations in the dog. However, both in terms of accuracy and reproducibility of results, Accu-Chek II and Chemstrip bG, gave the highest correlation coefficients and, as such, are probably of the greatest clinical value.     

Pharmacokinetics of phenobarbital in the horse

Pharmacokinetics of phenobarbital was examined in 6 mature horses after 12 mg of phenobarbital/kg of body weight was infused over 20 minutes. Biexponential decrease in serum phenobarbital concentrations was observed with a distribution-phase half-life of 0.101 +/- 0.086 hour (mean +/- SD) and a terminal-phase elimination half-life of 18.3 +/- 3.65 hours. The volume of distribution at steady state was 0.803 +/- 0.070 L/kg. Total body clearance of phenobarbital was 30.8 +/- 6.2 ml/h/kg. The high clearance in the horse seems to explain the markedly shorter half-life of phenobarbital in this species. Seemingly, 6.65 mg of phenobarbital/kg as a 20-minute infusion given every 12 hours would provide approximate peaks of 29 micrograms/ml and troughs of 15 micrograms/ml. A loading dose of 12 mg of phenobarbital/kg would be appropriate for this regimen.     

Cisplatin Therapy in 41 Dogs With Malignant Tumors

Forty-one dogs with a variety of histopathologically diagnosed, measurable tumors were treated with cisplatin (cis-diamminedichloroplatinum, Platinol, Bristol Laboratories, Syracuse, NY 13221-4755) as a single agent at a dosage of 60 mg/m2 given intravenously at 3-week intervals. In an attempt to avoid renal toxicity of cisplatin, saline diuresis was induced and maintained for 4 hours before and 2 hours following cisplatin administration. The dogs received one to ten doses of cisplatin. To determine response to therapy and to monitor toxicity of the drug, the dogs were evaluated with physical examinations including tumor measurements, radiography, complete blood counts, platelet counts, urinalyses, serum urea nitrogen concentrations, and serum creatinine concentrations. An overall response rate of 19% was observed. Complete remission occurred in one of 11 dogs with squamous cell carcinomas and one of one dog with a mediastinal undifferentiated carcinoma. Partial remissions were documented in one of 11 dogs with squamous cell carcinomas, two of three dogs with metastatic osteosarcomas, one of three dogs with nasal adenocarcinomas, and one of one dog with a thyroid adenocarcinoma. Toxic side effects were primarily gastrointestinal in nature, with vomiting occurring 1-6 hours after cisplatin administration in 27 of 41 dogs. Severe anorexia occurred in three dogs, and hemorrhagic diarrhea was observed in one dog. One dog developed grand mal seizures and died 3 hours following therapy. Granulocytopenia was documented in six dogs, and thrombocytopenia was observed in four dogs. One dog showed an increase in serum urea nitrogen and creatinine concentrations, but this patient had known pre-existing renal disease.(ABSTRACT TRUNCATED AT 250 WORDS)     

The effect of free amino acid levels in the blood and milk of cows on protein levels in milk

In the cows of the whole group under study, a significant negative relation (r = = -0.4797) was found between the histidine level in arterial blood and protein content in milk; further, there was a significant positive relation (r = 0.4624) between alanine level in milk and protein content in milk, and a significant negative relation (r = -0.5028) for the level of threonine. The group of cows with a higher milk output showed a significant negative relation between methionine level in milk and protein content in milk (r = -0.7482) and a highly significant negative relation between threonine level and protein content in milk (r = -0.8410). The negative relations of some amino acids to the content of protein in milk suggest that there is a poor supply of these amino acids for the production of protein in milk.     

A comparison of growth rates of normal thoroughbred foals and foals diagnosed with cervical vertebral malformation

The objectives of this study were to compare the growth rates of normal thoroughbred foals to previously reported growth rates¹ and to compare growth rates of normal foals with foals diagnosed with cervical vertebral malformation (CVM). Fifty-six foals from two foals crops were used, and eight of these foals were diagnosed with CVM. Growth rate analysis of the CVM foals had to be restricted to the period prior to diagnosis because once these foals were diagnosed, they were treated differently from the normal foals. Body measurements taken at 7 day intervals were body weight, wither height, hip height, and heart girth. For statistical analysis, data were broken down into 30 day intervals. Results showed that the growth rates for normal thoroughbred foals have not changed in the past fifteen years. The CVM foals tended to be heavier and taller during some time intervals than the normal foals, but there were no significant differences between the two groups in any of the skeletal growth measurements. Body weight gain was faster in CVM foals from 31–60 d (p<.01), 121–150 d (p<.01), and 211–240 d (P –.05).     

THE EFFECTS OF INTRA-ARTICULAR ANESTHESIA ON SOFT TISSUE-AND BONE-PHASE SCINTIGRAPHY IN THE HORSE

Soft tissue- and bone-phase scintigrams were acquired from 4 normal horses before and over a 14-day period after metacarpophalangeal, antebrachiocarpal, tarsocrural and tarsometatarsal joint blocks. Images were evaluated subjectively and quantitatively for increased activity in these regions. The antebrachiocarpal block resulted in obvious focal accumulation of activity on soft tissue-phase scintigrams. This increased activity was greatest 2 to 4 days postanesthesia and persisted up to 14 days postanesthesia. On quantitative analysis of soft tissue-phase images, similar trends were noted after the metacarpophalangeal and tarsocrural blocks, but these increases were relatively mild and were not evident on subjective evaluation of the images. Abnormal soft tissue-phase activity was not associated with the tarsometatarsal block. On bone-phase scintigrams, increased activity was not present following any of these joint blocks.     

The effect of vitamin a supplementation on seminal characteristics and vitamin a absorption in stallions

Fourteen mature stallions were paired based on age and pretreatment spermatozoal output. One member of each pair was assigned to either 1) control (3 ml corn oil) or 2) treated (132,000 IU retinyl palmitate in 3 ml corn oil) experimental groups. Treatments were added to oat rations every other day. Seminal characteristics (gel free volume, gel volume, total seminal volume, percent progressively motile spermatozoa, number of spermatozoa per ml, percentage morphologically normal spermatozoa and spermatozoal membrane stability) and total scrotal width of each stallion were recorded before (February) and after three months of vitamin A supplementation (June). Plasma vitamin A was measured at 0,6,12,24, and 48 hours following the first and last treatments to document absorption. There were no treatment effects (p>.05) on seminal characteristics or scrotal width. Seasonal increases were recorded in gel-free volume, total seminal volume, percent spermatozoal motility, total spermatozoal output, percentage of morphologically normal spermatozoa, and total scrotal width. Plasma vitamin A was lower during the second collection period (June) than the first (February) in both treatment groups. Peak plasma vitamin A was observed 48 hours following ingestion of the first dose of the vitamin but at 12 hours following the last treatment.